VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,508,895 | -42.6% | 792,526 | -18.8% | 0.00% | -33.3% |
| Q2 2023 | $18,302,400 | +36.0% | 976,128 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $13,456,269 | -19.1% | 933,167 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $16,623,624 | -52.1% | 859,102 | -15.0% | 0.00% | -57.1% |
| Q3 2022 | $34,718,000 | +79.8% | 1,010,708 | -20.0% | 0.01% | +75.0% |
| Q2 2022 | $19,305,000 | -63.9% | 1,263,384 | -46.1% | 0.00% | -55.6% |
| Q1 2022 | $53,538,000 | -63.1% | 2,346,047 | -40.4% | 0.01% | -60.9% |
| Q4 2021 | $145,251,000 | -32.0% | 3,939,508 | -14.3% | 0.02% | -36.1% |
| Q3 2021 | $213,551,000 | -8.0% | 4,594,226 | +15.9% | 0.04% | -7.7% |
| Q2 2021 | $232,082,000 | – | 3,965,479 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |